Workflow
饲料概念
icon
Search documents
傲农生物涨2.01%,成交额2.34亿元,主力资金净流出1915.87万元
Xin Lang Cai Jing· 2025-11-14 05:50
11月14日,傲农生物(维权)盘中上涨2.01%,截至13:17,报5.58元/股,成交2.34亿元,换手率 2.69%,总市值145.25亿元。 傲农生物所属申万行业为:农林牧渔-饲料-畜禽饲料。所属概念板块包括:饲料、低价、摘帽概念、猪 肉概念、中盘等。 截至9月30日,傲农生物股东户数7.49万,较上期增加62.69%;人均流通股21340股,较上期减少 38.53%。2025年1月-9月,傲农生物实现营业收入63.35亿元,同比减少8.52%;归母净利润4.14亿元,同 比增长150.54%。 分红方面,傲农生物A股上市后累计派现1.80亿元。近三年,累计派现0.00元。 责任编辑:小浪快报 资金流向方面,主力资金净流出1915.87万元,特大单买入806.52万元,占比3.44%,卖出1721.69万元, 占比7.35%;大单买入3799.71万元,占比16.22%,卖出4800.42万元,占比20.49%。 傲农生物今年以来股价涨57.63%,近5个交易日涨0.72%,近20日涨10.28%,近60日涨53.72%。 今年以来傲农生物已经2次登上龙虎榜,最近一次登上龙虎榜为8月27日,当日龙虎榜净 ...
正虹科技跌2.07%,成交额747.19万元,主力资金净流入35.75万元
Xin Lang Cai Jing· 2025-10-29 02:01
Core Viewpoint - Zhenghong Technology's stock price has shown a mixed performance this year, with a year-to-date increase of 6.79% but a recent decline in the short term, indicating potential volatility in the market [2]. Company Overview - Zhenghong Technology, established on March 12, 1997, and listed on March 18, 1997, is located in Yueyang, Hunan Province. The company specializes in the research, production, and sales of various types of feed, agricultural industrialization, and investment in biotechnology projects [2]. - The company's main revenue sources are feed sales (76.37%), pig sales (16.72%), feed raw material sales (6.15%), and other product sales (0.76%) [2]. Financial Performance - For the period from January to September 2025, Zhenghong Technology achieved an operating income of 797 million yuan, representing a year-on-year growth of 1.55%. However, the net profit attributable to the parent company was a loss of 10.48 million yuan, although this reflects a significant improvement with a year-on-year growth of 52.88% [2]. - The company has cumulatively distributed 164 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3]. Stock Performance - As of October 29, Zhenghong Technology's stock price was 7.08 yuan per share, with a market capitalization of 2.454 billion yuan. The stock has experienced a decline of 2.07% during the trading session [1]. - The stock has seen a decrease of 2.88% over the last five trading days, 0.84% over the last 20 days, and 8.76% over the last 60 days [2]. - The company had a net inflow of main funds amounting to 357,500 yuan, with a single large purchase accounting for 4.78% of the total [1].
傲农生物跌2.17%,成交额8646.74万元,主力资金净流出1344.91万元
Xin Lang Cai Jing· 2025-10-21 02:09
Core Points - The stock price of Aonong Biological dropped by 2.17% on October 21, trading at 4.96 CNY per share with a total market capitalization of 12.911 billion CNY [1] - Aonong Biological's stock has increased by 40.11% year-to-date, but has seen a decline of 7.98% over the last five trading days and 17.88% over the last twenty days [1] - The company has been listed on the "Dragon and Tiger List" twice this year, with the most recent net purchase of 14.9985 million CNY on August 27 [1] Company Overview - Aonong Biological, established on April 26, 2011, and listed on September 26, 2017, is located in Zhangzhou, Fujian Province [1] - The company's main business segments include feed (66.22%), breeding (20.95%), food (12.60%), and other (0.22%) [1] - As of June 30, the number of shareholders increased by 17.87% to 46,000, while the average circulating shares per person decreased by 7.64% to 34,720 shares [2] Financial Performance - For the first half of 2025, Aonong Biological reported a revenue of 3.957 billion CNY, a year-on-year decrease of 15.01%, while net profit attributable to shareholders increased by 166.81% to 361 million CNY [2] - The company has distributed a total of 180 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3]